Demand for Ambulatory Infusion Pumps in North America

An ambulatory infusion pump is a tiny battery-operated pump that gradually infuses your body with medications like chemotherapy or antibiotics. The pump releases medication over a predetermined period of time determined by your doctor. You may continue the majority of your daily tasks at home with the help of an AIP and avoid having to spend the night at the hospital.

To learn more about this report: https://bit.ly/3IzqJzC

Ambulatory services, which are a form of outpatient treatment, are rapidly growing in demand in North America as a result of the expanding population and demand on the healthcare system. This is mostly due to the fact that these treatments are more practical and affordable than those provided by conventional hospitals.

As a result, there are now many more ambulatory surgery centers (ASCs) than ever before in the U.S. The shorter stays, lesser risk of infections, quicker healing, and novel technology that ASCs provide can also be credited for their popularity.

Due to a shortage of visiting time and a heavy caseload, ambulatory services are becoming preferred over inpatient treatment in this aspect. Thus, the usage of infusion pumps in the area is influenced by the rising need for ambulatory services for the treatment of chemotherapy, diabetes, and other medical treatments.

The North American ambulatory infusion pumps market is predicted to reach $1,989.8 million by 2030 due to the increasing incidence of chronic illnesses, rising elderly and diabetic populations, and surging need for ambulatory services.

In the application category of ambulatory infusion pumps in North America, diabetes had the highest revenue share of around 30%.  This is because diabetes and its effects are becoming more common in the area. A whopping 96 million adults in the U.S., or 38.0% of the adult population, have prediabetes.

An infusion pump substitutes the requirement for many daily injections with a continuous insulin infusion by dispensing dosages of insulin at predetermined times. As a result, the need for ambulatory infusion pumps is anticipated to increase as the number of diabetes patients rises over time.

Additionally, the advancements in wearable diabetes control devices and their protracted infusion times are to blame for their growing popularity.

Due to the existence of significant competitors, a well-developed healthcare infrastructure, benevolent reimbursement rules, and the rising frequency of chronic illnesses, the U.S. controlled a bigger share. 

Additionally, the proliferation of alternative healthcare settings and the adoption of various home infusion services are factors in the sector. It is predicted that the U.S.'s substantial hospital population will continue to fuel regional demand. 

A total of 6,093 hospitals, including 1,228 investor-owned (for-profit) community hospitals and 2,960 non-government not-for-profit community hospitals, were in operation in the United States as of 2010, according to the American Hospital Association (AHA).

In terms of product categories, the demand for ambulatory infusion pumps was dominated by accessories and consumables. This is mainly because they make repeat purchases and a variety of accessories and consumables are readily available around the region.

Over 40% of the demand was accounted for by devices. This is mostly attributable to these pumps' great availability and increased demand due to their convenience in providing medications for a variety of diseases.

Read More

Hematology Testing Is Important for People with Blood Disorders

A branch of medicine called clinical hematology deals with diseases of the blood. Hematologists and hematopathologists are highly skilled medical specialists that are required for treating blood and marrow disorders. This comprises the blood and bone marrow cells.

Numerous blood disorders, including anemia, leukemia, infections, irregular blood coagulation, and side effects from chemotherapy can be diagnosed with hematology testing. A variety of tests are used to help determine what's wrong with your blood or the organs that deal with it. You should seek out assistance from a Coimbatore hematologist as soon as possible to diagnose any blood problems.

Malignant lymphomas, leukemia, anemia, blood transfusion, myelofibrosis, and bone marrow stem cell transplantation are a few of the blood-related disorders. Iron deficiency, vitamin B12 insufficiency, chronic lead poisoning, and red blood cell disintegration are just a few of the factors that contribute to anemia.

Moreover, women are more prone to anemia. A genetic blood condition called hemophilia causes improper blood clotting. When blood transforms from a liquid to a solid, clusters called blood clots to develop.

Additionally, according to WHO estimates, 40% of pregnant women and 42% of children under the age of 5 are anemic globally. By 2030, it is expected that the hematology diagnostics market would be worth USD 6,335.9 million. The increase in the incidence of blood-related disorders, rapid use of high throughput hematology analyzers, and technical developments may all be contributing factors to this.

To learn more about this report: https://bit.ly/3MwzawV

The medical specialty of hematology focuses on diseases of the blood and those that are connected to it. To assess a range of blood problems, hematology tests include numerous examinations of the blood-producing organs and blood proteins.

Hematologists can research and treat a variety of conditions that predominantly impact the blood. Several instances include:

Anemia: Due to insufficient production of healthy red blood cells, the body cannot transport adequate oxygen throughout the body.

Sickle Cell Disease: The morphology of red blood cells is altered by this type of anemia.

Thalassemia: This occurs when the body does not produce enough hemoglobin.

Bleeding Disorders: These hinder the body's ability to properly build blood clots.

Thrombocytopenia: Due to the low platelet count involved, blood clot formation may be challenging.

Malaria: Red blood cells may be destroyed by this illness.

Von Willebrand’s Disease: People without von Willebrand factor in their blood have this bleeding condition.

Hypercoagulability: This defines the blood's elevated risk of clotting.

Blood Cancers: These may have an impact on how well a person's blood cells work.

The rising prevalence of blood disorders has led to a rise in the usage of hematology diagnostics in recent years. The need for hematological diagnostics is also being fueled by an aging population, technological improvements, and increase in the demand for better healthcare facilities, as well as an increase in government initiatives to promote healthcare infrastructure.

Hematology tests are crucial for discovering and diagnosing blood-related diseases as well as supporting medical operations. The number of hematological tests is increasing as a result of people's increased use of these tests due to increased health awareness.

Read More

Hospitals Dominated the Medical Ceramics Industry

The total revenue generated by the medical ceramics industry was USD 2,543.2 million in 2022, and will grow at a compound annual growth rate of 7.3% during the projected period, to touch USD 4,477.7 million by 2030.

To learn more about this report: https://bit.ly/3WnBZ7Q

The increasing occurrence of musculoskeletal conditions, including osteoporosis, rheumatoid arthritis, osteoarthritis, fractures, sarcopenia, and sports injuries, is powering the requirement for hip and knee replacement surgeries all over the world.

According to the WHO, musculoskeletal disorders are the foremost causes of disability, with lower back pain impacting the quality of life. In all, about 1.71 billion people are living with musculoskeletal conditions.

Furthermore, as per the Centers for Disease Control and Prevention, about 25% adults, or about 58.5 million people, in the U.S. are suffering from arthritis. These continually rising numbers, have a significantly affected the demand for medical ceramics, as they are extensively used in the manufacturing of knee and hip replacements.

The dental application had the major share, about 40%, because of the growing incidence of periodontic disorders. As per the estimates of American Academy of Implant Dentistry, the people with dental implants in the U.S.  were 3 million, increasing at a shocking rate of 500,000 yearly.

Hospitals dominated the medical ceramics market. As they are the preliminary contact point for most people, the requirement for in-hospital surgical treatments is rising, because of the enormous rise in the incidence of musculoskeletal conditions. Hospitals have advanced facilities, accompanied by highly skilled professionals, allowing them to offer complete care.

Moreover, hospitals will have the fastest growth, with a rate of  about 8%, in the future. This is because of the upgradation of the healthcare infra by government and private players.

North America dominated the industry with over 40%, as per a report by P&S Intelligence. It will maintain its lead in the future as well, primarily because of the increasing number of dental implant procedures and the increasing count of orthopedic surgical procedures.

It has a lot to do with the increasing elderly population, that the demand for medical ceramics will continue to rise in the future.

Read More

North America Led the Cell & Gene Therapy Manufacturing Services Industry

According to a statement by a market research institution, P&S Intelligence, the cell & gene therapy manufacturing services market generated a value of USD 5,151 million in 2022, and it will reach USD 20,164 million, propelling at an 18.60% compound annual growth rate, by 2030.

To learn more about this report: https://bit.ly/3BLTc1f

The growth in the industry is credited to factors such as the numerous therapy development activities, the high cases of cancer as well as other target illnesses, and increased pharmaceutical research and development expenses.

In 2022, the cell therapy category accounted for a larger revenue share in the industry, of approximately 62%. This is primarily attributed to the extensive adoption of cell-based therapy for the clinical investigation of cardiovascular illnesses, because of rigorous pre-clinical studies of phenotypic efficacy, cell biology, immunology, and mechanism of action.

In 2022, the cell & gene therapy manufacturing services market was led by North America, with a revenue share of approximately 49%. This is because of the growing number of product launches, the rising emphasis on the treatment of rare diseases, the mounting prevalence of cancer cases, the existence of key industry players, and the increasing number of clinical trials in the region. Furthermore, advancements in technology in the region are boosting the requirement for gene therapies.

Europe accounted for a significant share of the industry. Approximately one-third of the overall population of 15 years and above are suffering from at least two chronic illnesses in the region, due to unhealthy diets, mounting alcohol consumption, and growing habits of smoking in the region.

Hence, with the high prevalence of cancer and other targeted illnesses, numerous therapy development activities, and increasing pharmaceutical research and development expenses, the global cell & gene therapy manufacturing services industry will grow significantly in the years to come. 

Read More

Global Lung Cancer Surgery Industry Will Reach $7.79 Billion by 2030

The lung cancer surgery market was USD 5.65 billion in 2022, and it is likely to propel at a rate of 4.10% from 2022–2030, to reach USD 7.79 billion by 2030, as per a report by P&S Intelligence. The rising incidence of lung cancers, increasing tobacco smoking by younger generation, growing elderly population, and reimbursement availability are driving the growth of the industry.

To learn more about this report: https://bit.ly/3pRiZ5y

The thoracotomy category had the larger share of revenue in 2022, of over 62%. The dominance of this category is mostly credited to the increasing number of lung cancer surgeries, such as lobectomy, sleeve resection, segmentectomy, and pneumonectomy.

As per the Journal of Thoracic Disease, around 222,520 surgical operations are conducted every year for lung cancer. The lobectomy accounts for a 68.2% share, and it is the most-common thoracic surgery. Wedge resection surgery has an 18.1% share.

Moreover, the use of powered surgical instruments is rising because they allow for quicker procedures with outstanding functionality and reliable performance compared to the manual instruments. 

Moreover, the key players are laying emphasis on launching new technologies, for meeting the growing demand for  advanced instruments with high flexibility and usability, the requirement for which is burgeoning in lung cancer surgeries.

Due to the rising number for lung cancer surgeries and funding from governments, a lung cancer surgery market growth of 4.6% is projected in the surgical instruments category in the near future. It is because every surgery requires some kind of instruments, such as cautery, scalpels, retractors, suction pumps and tubes, forceps, scissors, clamps, and IV needles and tubing.

APAC will have the fastest growth in the near future because of the rapid healthcare infrastructure development, increasing funding by government and initiatives for raising awareness, and growing medical tourism industry in India and China.

Hence, with the rising elderly population and the rising number of awareness campaigns, the demand for  lung cancer surgeries will grow considerably in the years to come.

Read More

Healthcare Bioconvergence Market To Reach USD 216 Billion by 2030

The healthcare bioconvergence market was valued at USD 122 billion by 2022 will advance at 7.5% CAGR during the projected period, to touch USD 216 billion by 2030.

The market is on the rise due to the increasing count of elderly people and the growing usage of stem cells for regenerating organs, tissues, and injured cells. 

Moreover, the fondness of end users for combinations of cutting-edge technologies, including ML, robotics, ergonomics, and AI, with cloud computing and biology, will come in handy toward the development of the industry in the years to come.

The drug discovery category dominated the industry with a share of approximately 22%, in 2022, because of the growing burden of CVDs, cancer, and CNS related disorders, increasing costs of medical treatments, and the patent expiry of numerous medications. 

As per the several government records, in the U.S., about 1.9 million new cancer cases were documented and about 609,360 deaths were resulted by it in 2022.

Pharma and biotech companies are growing considerably, credited to the quickly growing count of clinical trials and the increasing acceptance of advanced techniques by them for development of drugs. These companies are targeting to bring medicines faster, more efficiently, and at lesser costs, accompanied by focusing on patient safety. 

Furthermore, extensive research is conducted on mRNA’s pertinence in treating non-infectious diseases, for example cancer. 

The Fourth Industrial Revolution is altering the way treatment and diagnosis are done and hastening the procedure of the new drug discovery. The acceptance of IoT and AI, is powering this revolution. Amidst this, healthcare is converting into a cyber– physical system with, IoT, RFID, medical robots, intelligent sensors, and many other objects and technologies, which are now also armed with cloud computing, big data analysis, and decision support methods.

Europe is leading the healthcare bioconvergence market, as stated by a market expert at P&S Intelligence and this will continue by the end of this decade, with USD 73 billion.  The region is growing because of the existence of important, medical centers, research institutes, and hospitals. 

For example, in February 2021, LifeArc, U.K.-based medical research firm reinforced the work of the Gen OMICC COVID-19 project by proclaiming funding of USD 5.74 million. The funding was to assist the project in sample gathering and handing, patient enrollment, along with patient bioinformatics analysis.

Furthermore, Europe has a well-established medical industry, propelling the demand for new-generation healthcare technologies.

Due to the increasing use of stem cells for regenerating tissues, organs and injured cells, the demand for healthcare bioconvergence will continue to grow in the years to come, all over the world.

Read More

Electric Trucks are Revolutionizing the Road in the U.S.

The automotive industry in the U.S.  is undergoing a remarkable transformation in recent years, as the push for greener and more sustainable transportation increases. There has been a significant rise in the use of electric vehicles in the country.  With electric cars garnering substantial attention, the focus is now shifting toward electric trucks.

An electric truck can be any type of truck, semi-truck, heavy-duty commercial, or military truck driven by batteries designed to carry payloads, transport cargo, or perform other utilitarian work.

The Increasing Requirement for Electric Trucks

With environmental concerns and carbon emission reduction becoming increasingly vital, the requirement for electric trucks in the U.S. has been gaining momentum. They offer several advantages over their conventional counterparts, such as reduced greenhouse gas emissions, decreased fuel costs, and improved efficiency. This combination of environmental sustainability and economic benefits has attracted the attention of stakeholders, including consumers, fleet operators, and policymakers toward electric trucks.

The U.S. government has taken numerous initiatives to encourage e-mobility and also placed stringent emission standards on fossil fuel-powered commercial vehicles.

The industry of electric trucks in the U.S. will reach USD 15,084.3 million by the end of this decade. 

Environmental Benefits

Electric trucks have revolutionized the transportation industry by significantly reducing greenhouse gas emissions. Unlike traditional diesel-powered trucks, which emit large amounts of carbon dioxide and other pollutants, electric ones produce zero tailpipe emissions. Transitioning to electric trucks can contribute toward breathing cleaner air and reduce the effects of climate change. 

Electric trucks also have the capability of running silently because they run on an electric motor instead of an engine. Therefore, reducing noise pollution. Additionally, e-vehicles are virtually silent, and they help in reducing noise pollution.

Low Maintenance Cost

Electric trucks have a relatively low maintenance expenses as they don’t have as many moving parts as an internal combustion automobile. The requirement of servicing for electric trucks is lesser than the traditional diesel or gasoline trucks. Thus, the yearly expenditure of running an e-truck is significantly low.

Use of Electric Trucks in Logistics

The transportation industry is shifting toward e-trucks to advance efficiency in delivering goods. The progression of batteries and the new motors can promote the adoption of e-vehicles in urban logistics to deliver orders to home or physical points of sale. 

With not consuming fossil fuels, these automobiles can reduce logistics expenses.

The increasing logistics footprint and notable development in retail, third-party logistics, and e-commerce are boosting the adoption of such environmentally friendly commercial automobiles in the nation.

Additionally, with the rising requirement for quicker and more convenient deliveries at the doorstep, the necessity for effective supply chains for logistics services is increasing.

Hence, it is because of the low maintenance and operation cost of electric trucks, reducing cost of batteries, and a number of supportive initiatives taken by the government, the requirement for electric truck will continue to increase in the years to come in the U.S.

Read More